DOCN vs GEN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

DOCN

44.9
AI Score
VS
DOCN Wins

GEN

33.7
AI Score

Investment Advisor Scores

DOCN

45score
Recommendation
HOLD

GEN

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DOCN GEN Winner
Revenue 539.09M 1.34B GEN
Net Income 51.21M 215.00M GEN
Gross Margin 55.5% 77.0% GEN
Net Margin 9.5% 16.1% GEN
Operating Income 65.94M 443.00M GEN
ROE 5.5% 8.1% GEN
ROA 1.6% 1.4% DOCN
Total Assets 3.12B 15.64B GEN
Cash 767.03M 384.00M DOCN
Debt/Equity 0.99 3.07 DOCN
Current Ratio 1.31 0.47 DOCN
Free Cash Flow 75.31M 430.00M GEN

Relative Price Performance (Last 90 Days)

DOCN 1M: -11.8% · 3M: -27.0% GEN 1M: +15.4% · 3M: +16.4%

Current Technical Phase

DOCN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.4%), weak momentum, RSI 42

RSI (14): 42.4 · Price: $115.64

GEN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.8% over 20 days), RSI 60

RSI (14): 59.6 · Price: $28.93

Fundamentals Snapshot

Metric DOCN GEN
Market Cap
Forward P/E 62.5 10.1
Trailing P/E 52.9 16.5
Revenue (TTM)
Revenue Growth 0.3% 0.1%
Gross Margin 0.6% 0.8%
Operating Margin 0.1% 0.4%
EPS 2.16 1.71
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, DOCN is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.